End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.017 AUD | +6.25% | +13.33% | -15.00% |
04-10 | Syntara Reaches 50% Recruitment in Phase 2 Trial for Bone Marrow Cancer Treatment | MT |
02-29 | Syntara Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Business Summary
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Mannitol
100.0
%
| 7 | 100.0 % | 6 | 100.0 % | -22.37% |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Australia
100.0
%
| 7 | 100.0 % | 6 | 100.0 % | -22.37% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gary Phillips
CEO | Chief Executive Officer | 62 | 11/03/03 |
Director of Finance/CFO | 67 | 30/11/02 | |
Jana Baskar
CTO | Chief Tech/Sci/R&D Officer | - | 30/06/22 |
Kristen Morgan
LAW | General Counsel | - | 31/07/08 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Phillips
CEO | Chief Executive Officer | 62 | 11/03/03 |
Director of Finance/CFO | 67 | 30/11/02 | |
Kathleen Metters
CHM | Chairman | 66 | 06/06/17 |
Hashan de Silva
BRD | Director/Board Member | - | 15/01/23 |
Simon Green
BRD | Director/Board Member | - | 15/12/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 831,006,340 | 819,152,136 ( 98.57 %) | 0 | 98.57 % |
Company contact information
Sector
Sales per Business
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.00% | 13.24M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- SNT Stock
- Company Syntara Limited